Van Straalen K.R., Tzellos T., Alavi A., Benhadou F., Cuenca-Barrales C., Daxhelet M., Daoud M., Efthymiou O., Giamarellos-Bourboulis E.J., Guillem P., Gulliver W., Jemec G.B.E., Katoulis A., Koenig A., Lazaridou E., Lowes M.A., Marzano A.V., Matusiak L., Molina-Leyva A., Moltrasio C., Pinter A., Potenza C., Prens E.P., Romaní J., Saunte D.M., Sayed C., Skroza N., Stergianou D., Szepietowski J.C., Trigoni A., Vilarrasa E., Kyrgidis A., Zouboulis C.C., Van Der Zee H.H.. External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort. DERMATOLOGY. 2023; 239(3)DOI:10.1159/000528968. PMID:36630943. IF:3.000(Q2/4D).

Pereira M.P., Weisshaar E., Halvorsen J.A., Wallengren J., Legat F.J., Garcovich S., Savk E., Reich A., Bozek A., Lvov A., Bobko S., Metz M., Streit M., Misery L., Brenaut E., Serra-Baldrich E., Gonçalo M., Szepietowski J.C., Augustin M., Nau T., Zeidler C., Ständer S.. Chronic prurigo: Insufficient disease control in spite of high healthcare usage. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(6)DOI:10.1111/jdv.18903. PMID:36682045. IF:8.500(Q1/1D).

Carrascosa J.M., Vilarrasa E., Belinchón I., Herranz P., Crespo J., Guimerá F., Olveira A.. [Translated article] Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts [Abordaje común del paciente con psoriasis y riesgo de esteatosis hepática metabólica: recomendaciones de un grupo de expertos multidisciplinar]. Actas Dermo-Sifiliograficas. 2023; 114(5)DOI:10.1016/j.ad.2023.04.013. PMID:37068635. IF:(Q/D).

Yélamos O., Geller S., Tokez S.. Skin cancer special issue in Skin Health and Disease. Skin Health And Disease. 2023; 3(2)DOI:10.1002/ski2.224. PMID:37013119. IF:(Q/D).

Fustà-Novell X., García-Herrera A., Yélamos O.. [Translated article] BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis [Tumor melanocítico inactivado a BAP1: claves para su diagnóstico dermatoscópico]. Actas Dermo-Sifiliograficas. 2023; 114(2)DOI:10.1016/j.ad.2022.11.008. PMID:36464005. IF:(Q/D).

Olveira A., Augustin S., Benlloch S., Ampuero J., Suárez-Pérez J.A., Armesto S., Vilarrasa E., Belinchón-Romero I., Herranz P., Crespo J., Guimerá F., Gómez-Labrador L., Martín V., Carrascosa J.M.. The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life-Basel. 2023; 13(2)DOI:10.3390/life13020419. PMID:36836776. IF:3.200(Q1/3D).

Rivera-Díaz R., Pozo T., Alfageme F., Díaz Ley B., Osorio G.F., Chico R., Vilarrasa E., Silvente C., Ciudad Blanco C., Romaní J., Martorell A., Fernández P., Romero Ferreiro C., Molina Leyva A.. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.013. PMID:37331620. IF:(Q/D).

Pereyra-Rodriguez J.J., Herranz P., Figueras-Nart I., Perez B., Elosua M., Munera-Campos M., Melgosa-Ramos J., Zaragoza V., Silvestre J.F., Campos-Domínguez M., Guilabert A., Miquel J., Alcantara-Luna S., de la Cueva P., Serra-Baldrich E., Armario-Hita J.C.. Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(3)DOI:10.18176/jiaci.0831. PMID:35671128. IF:6.700(Q1/2D).